Methods of inducing IL-10 production

Details Methods of inducing IL-10 production Methods of inducing IL-10 production

2011-04-05

2011-04-05

Woodward, Cherie M (Department: 1647)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

C514S008100

Reexamination Certificate

active

07919097

ABSTRACT:
The invention provides a method of inducing IL-10 production.

REFERENCES:
patent: 6605699 (2003-08-01), Ni et al.
Rabinovich et al., (Trends Immunol. Jun. 2002;23(6):313-20).
Santucci et al., (Gastroenterology. May 2003;124(5):1381-1394).
Zuniga et al., (Infect Immun. Nov. 2001 ;69(11):6804-12).
Abbas et al., “Functional diversity of helper T lymphocytes”,Nature, 383:787-793 (1996).
Allione et al., “β-Galactoside-Binding Protein (βGBP) Alters the Cell Cycle, UP-Regulates Expression of the α- and β-Chains of the IFN-7-γ Receptor, and Triggers IFN-γ-Medicated Apoptosis of Activated Human T Lymphocytes”,J. Immunol., 161:2114-2119 (1998).
Asadullah et al., “Interleukin-10 Terhapy- Review of a New Approach”,Pharmacol. Rev., 55(2):241-269 (2003).
Asseman et al., “An Essential Role for Interleukin 10 in the Function of Regulatory T Cells That Inhibit Intestinal Inflammation”,J. Exp. Med., 190(7):995-1003 (1999).
Barondes et al., “Galectins: A Family of Animal β- Galactoside-Binding Lectins”,Cell, 76:597-598 (1994).
Barondes et al., “Structure and function of a large family of animal lectins”J. Biol. Chem., 269(33):20807-20810 (1994).
Baum et al., “Amerlioration of graft versus host disease by galectin-1”,Clin. Immunol., 109(3):295-307 (2003).
Baum et al., “Synthesis of an endogeneous lectin, galectin-1, by human endothelial cells is up-regulated by endothelial cell activation”,Glycoconj. J., 12:63-68 (1995).
Brady et al., “Reflections on a peptide”,Nature, 368:692-693 (1994).
Cho et al., “Galectin-1, a β-Galactoside-binding Lectin in Chinese Hamster Ovary Cells”,J. Biol. Chem., 270(10):5198-5206 (1995).
Colombel et al., “Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease”,Gut, 49:42-46 (2001).
Davenport et al., “Inhibition of pro-inflammatory cytokine generation by CTLA4-Ig in the skin and colon of mice adoptively transplanted with CD45RBhiCD4+T cells correlates with suppression of psoriasis and colitis”,Int. Immunopharmacol., 2:653-672 (2002).
Del Prete et al., “Human IL-10 is Produced by Both Type 1 Helper (TH1) and Type 2 Helper (TH2) T Cell Clones and Inhibits Their Antigen-Specific Proliferation and Cytokiine Production”,J. Immunol., 150(2):353-360 (1993).
Delioukina et al., “Galectin-1 Ameliorates The Development and Severity of GVHD in a Murine Model”,Blood, Abstract #1739, 94(10 Supp. 1):392A (1999).
Dias-Baruffi et al., “Dimeric Galectin-1 Induces Surface Exposure of Phosphatidylserine and Phagocytic Recognition of Leukocytes without Inducing Apoptosis”,J. Biol. Chem., 278(42):41282-41293 (2003).
Emmanouilides et al., “Prevention of experimental acute GVHD with galectin-1 and effects on immunologic reconstitution”,Blood, Abstract 904, 90(10 Supp. 1):205A (1997).
Fedorak et al., “Recombinant Human Interleukin 10 in the Treatment of Patients With Mild to Moderately Active Crohn's Disease”,Gastroenterol., 119:1473-1482 (2000).
Hara et al., “IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens in Vivo”,J. Immunol., 166:3789-3796 (2001).
International Search Report for PCT IB2004/004437, mailed Oct. 10, 2005.
Jameson et al., “A rationally designed CD4 analogue inhibits experimental allergic encephalomyelitis”,Nature, 368:744-746 (1994).
Kimball et al., Clinincal and Immunologic Assessment of Patients With Psoriasis in a Randomized, Double-blind, Placebo-Controlled Trial Using Recombinant Human Interleukin 10,Arch. Dermatol., 138:1341-1346 (2002).
Krensky et al., T-Lymphocyte-antigen interactions in transplant rejection,N. Engl. J. Med., 322(8):510-517 (1990).
Kühn et al., Interleukin-10-Deficient Mice Develop Chronic Enterocolitis,Cell, 75:263-274 (1993).
Leach et al., “Inflammatory Bowel Disease in C B-17scidMice Reconstituted with the CD45RBhighSubset of CD4+T Cells”,Am. J. Pathol., 148(5):1503-1515 (1996).
Levi et al., “Prevention and therapy with electrolectin of experimental auto immune myasthenia gravis in rabbits”,Eur. J. Immunol., 13:500-507 (1983).
Liu, “Galectins: A New Family of Regulators of Inflammation”,Clin. Immunol., 97(2):79-88 (2000).
Macatonia et al., “Differential Effect of IL-10 on Dendritic Cell-Induced T Cell Proliferation and IFN-γ Production”,J. Immunol., 150(9):3755-3765 (1993).
McInnes et al., “IL-10 Improves Skin Disease and Modulates Endothelial Activation and Leukocyte Effector Function in Patients with Psoriatic Arthritis”J. Immunol., 167:4075-4082 (2001).
Offner et al., “Recombinant human β-galactoside binding lectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis”,J. Neuroimmunol., 28:177-184 (1990).
Pace et al., “Restricted Receptor Segregation into Membrane Microdomains Occurs on Human T Cells During Apoptosis Induced by Galectin-1”,J. Immunol., 163:3801-3811 (1999).
Pace et al., “Cutting Edge: CD7 Delivers a Pro-Apoptotic Signal During Galectin-1-Induced T Cell Death”,J. Immunol., 165:2331-2334 (2000).
Perillo et al., “Galectin-1, an Endogenous Lectin Produced by Thymic Epithelial Cells, Induces Apoptosis of Human Thymocytes”,J. Exp. Med., 185(10):1851-1858 (1997).
Perillo et al., “Apoptosis of T cells mediated by galectin-1”,Nature, 378:736-739 (1995).
Powrie et al., “Phenotypically distinct subsets of CD4+T cells induce or protect from chronic intestinal inflammation in C. B-17scidmice”,Int. Immunol., 5(11):1461-1471 (1993).
Rabinovich et al., “Galectins: an evolutionarily conserved family of animal lectins with multifunctional properties; a trip from the gene to clinical therapy”,Cell Death Differ., 6:711-721 (1999).
Rabinovich et al., Molecular mechanisms implicated in galectin-1-induced apoptosis: activation of the AP-1 transcription factor and downregulation of BcI-2,Cell Death Differ., 7:747-753 (2000).
Rabinovich et al., “Induction of allogenic T-cell hyporesponsiveness by galectin-1-medicated apoptotic and non-apoptotic mechanisms”,Cell Death Differ., 9:661-670 (2002).
Rabinovich et al., “Specific inhibition of T-cell adhesion to extracellular matrix and proinflammatory cytokine secretion by human recombinant galectin-1”,Immunol., 97:100-106 (1999).
Rabinovich et al., “Recombinant Galectin-1 and Its Genetic Delivery Suppress Collagen- induced Arthritis via T Cell Apoptosis”,J. Exp. Med., 190(3):385-397 (1999).
Reich et al., “Response of Psoriasis to Interleukin-10 is Associated with Suppression of Cutaneous Type 1 Inflammation, Downregulation of the Epidermal Interleukin-8/CXCR2 Pathway and Normalization of Keratinocyte Maturation”,J. Invest. Dermatol., 116:319-329 (2001).
Roncarolo et al., “Type 1 T regulatory cells”,Immunol. Rev., 182:68-79 (2001).
Santucci et al., “Galectin-1 Suppresses Experimental Colitis in Mice”,Gastroenterol., 124:1381-1394 (2003).
Santucci et al.,“Galectin-1 Exerts Immunomodulatory and Protective Effects on Concanavalin A-Induced Hepatitis in Mice”,Hepatol., 31:399-406 (2000).
Schlaak et al., “T Cells Involved in Psoriasis Vulgaris Belong to the TH1 Subset”,J. Invest. Dermatol., 102:145-149 (1994).
Schreiber et al., “Safety and Efficacy of Recombinant Human Interleukin 10 in Chronic Active Crohn's Disease”,Gastroenterol., 119:1461-1472 (2000).
Stelmach et al., “A randomized, double-blind trial of the effect of glucocorticoid, antileukotriene and β-agonist treatment on IL-10 serum levels in children with asthma”,Clin. Exp. Allergy, 32:264-269 (2002).
Stämpfli et al., “Interleukin-10 Gene Transfer to the Airway Regulates Allergic Mucosal Sensitization in Mice

Affiliated with

Also associated with

Rating

Methods of inducing IL-10 production does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of inducing IL-10 production, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of inducing IL-10 production will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2704196